The initial mdr 2432235-2014-00703 was filed on december 4, 2014.Additional information (05/06/15): siemens technical operations investigated the issue which was reviewed on 5/6/15, where internal studies and testing on reagent lot 170 returned by the customer, showed no discordant patient results.Quality control samples and whole blood samples with assigned target values were tested with reagent lot 170 and recovered as per specifications.Additional information (5/8/2015): siemens headquarters support center (hsc) contacted the customer, and were informed on 5/8/15 that the customer had moved on to a different reagent lot and has had no problems.The cause of the falsely high results on patient samples for hemoglobin a1c_3 is unknown.The instrument is performing according to specifications.No further evaluation of the device is required.
|